Kades & Cheifetz’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $65.4K | Hold |
20,000
| – | – | 0.03% | 108 |
|
|
2024
Q3 | $77K | Hold |
20,000
| – | – | 0.04% | 94 |
|
|
2024
Q2 | $61.8K | Hold |
20,000
| – | – | 0.04% | 92 |
|
|
2024
Q1 | $51.6K | Hold |
20,000
| – | – | 0.03% | 90 |
|
|
2023
Q4 | $50K | Hold |
20,000
| – | – | 0.04% | 80 |
|
|
2023
Q3 | $40.6K | Buy |
+20,000
| New | +$40.6K | 0.03% | 74 |
|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$60.6K | – | 76 |
|
|
2023
Q1 | $60.6K | Hold |
20,000
| – | – | 0.05% | 76 |
|
|
2022
Q4 | $46.6K | Buy |
+20,000
| New | +$46.6K | 0.04% | 74 |
|